OTC · Financial Statements

BioForce Nanosciences Holdings, Inc. (BFNH) Financial Statements

$1.35 OTC: BFNH Market Cap $45.29M

BioForce Nanosciences Holdings, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$0$0$0$0
Net Profit$-1.0M$0$0$0$-1.0M
EPS$-0.02$-0.02$-0.02$-0.02$-0.04
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$1.0M$2.0M$2.0M$1.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-1.36
EV / EBITDA-95.70
FCF Yield-0.09%
Quick Ratio0.01
Interest Coverage0.00
Return 1Y80.00%
Return 3Y-38.64%
Return 5Y12.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksAll stock screens
BFNH Overview BFNH Dividend Run Stock Screener